The significance of dynamin 2 expression for prostate cancer progression, prognostication, and therapeutic targeting.

Xu, Bin; Teng, Liang Hong; Silva, Sabrina Daniela da; Bijian, Krikor; Al Bashir, Samir; Jie, Su; Dolph, Michael; Alaoui-Jamali, Moulay A; Bismar, Tarek A

Xu, Bin; Teng, Liang Hong; Silva, Sabrina Daniela da; Bijian, Krikor; Al Bashir, Samir; Jie, Su; Dolph, Michael; Alaoui-Jamali, Moulay A; Bismar, Tarek A.

Affiliation

Xu B; Segal Cancer Center and Lady Davis Institute for Medical Research, Department of Oncology and Medicine, McGill University, Montreal, Quebec, Canada.

Cancer Med ; 3(1): 14-24, 2014 Feb.

Article in En | MEDLINE | ID: mdl-24402972

Subject(s)

Carcinogenesis/genetics; Cell Movement/genetics; Dynamin II/biosynthesis; Prostatic Neoplasms/genetics; Adult; Aged; Aged, 80 and over; Cell Line, Tumor; Disease-Free Survival; Dynamin II/genetics; Gene Expression Regulation, Neoplastic; Humans; Lymphatic Metastasis/genetics; Lymphatic Metastasis/pathology; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Grading; Prognosis; Prostatectomy; Prostatic Neoplasms/mortality; Prostatic Neoplasms/pathology

Key words

Cancer-specific mortality; castration resistance; dynamin; prostate cancer; therapeutic target

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Cell Movement / Dynamin II / Carcinogenesis Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Cancer Med Year: 2014 Document type: Article Affiliation country: Canada Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google